Everybody should probably head over to twitter and like these tweets.
Michael Davidson MD
?
@mdavidsonmd
Nov 17
More
Why we need much higher levels of EPA to reduce CV risk which only prescription omega-3's such as Vascepa or Epanova can provide.
3 replies 10 retweets 34 likes
Reply 3 Retweet 10 Liked 34 Direct message
Pablo Corral MD
?
@drpablocorral
21h21 hours ago
More
Which is the mechanism by the EPA reduce the CV risk? Not TG effect...
1 reply 1 retweet 2 likes
Reply 1 Retweet 1 Like 2 Direct message
Sergio Kaiser, M.D., PhD, F.A.C.C.
?
@pabeda1
Follow Follow @pabeda1
More
Replying to @drpablocorral @mdavidsonmd
Pablo, While re-reading REDUCE-IT, I noticed that pts w/low HDL/High tgl had a 38% RRR reduction as compared to those w/opposite profile. P for interaction was 0.04. This might suggest benefits from ?? tgl. However, same patients have a proinflammatory and...(see below)
4:15 PM - 18 Nov 2018 from Rio de Janeiro, Brazil
1 Retweet 2 Likes Sharon ConklinJohnCappello
1 reply 1 retweet 2 likes
Reply 1 Retweet 1 Liked 2 Direct message
Sharon ConklinTweet text
New conversation
Sergio Kaiser, M.D., PhD, F.A.C.C.
?
@pabeda1
17h17 hours ago
More
Replying to @pabeda1 @drpablocorral @mdavidsonmd
...And prothrombotic profile. And Vascepa may rather be acting upon thes two axes, regardless of tgl lowering, even in those w/atherogenic dyslipidemic phenotype.
1 reply 1 retweet 3 likes
Reply 1 Retweet 1 Liked 3 Direct message
Sergio Kaiser, M.D., PhD, F.A.C.C.
?
@pabeda1
17h17 hours ago
More
Let alone anti-arrhythmic and cell-membrane stabilizing properties that only pertain to EPA, not to DHA.
0 replies 1 retweet 6 likes
Reply Retweet 1 Liked 6 Direct message